Cargando…
Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
Autor principal: | Syed, Yahiya Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624698/ https://www.ncbi.nlm.nih.gov/pubmed/37906372 http://dx.doi.org/10.1007/s40265-023-01965-7 |
Ejemplares similares
-
Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023) -
Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study
por: Gonzalez-Salinas, Roberto, et al.
Publicado: (2021) -
Correction to: Sparsentan: First Approval
por: Syed, Yahiya Y.
Publicado: (2023) -
Correction to: Regdanvimab: First Approval
por: Syed, Yahiya Y.
Publicado: (2021) -
Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)
por: Yeu, Elizabeth, et al.
Publicado: (2023)